How has been the historical performance of Tejnaksh Health.?
Tejnaksh Health's historical performance shows fluctuating net sales, increasing from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, but down from a peak of 19.76 Cr in Mar'19. While profitability has improved, total assets and sales remain below historical highs.
Answer:The historical performance of Tejnaksh Health shows a fluctuating trend in net sales and profitability over the years. Breakdown:
Tejnaksh Health's net sales increased from 11.73 Cr in Mar'23 to 12.90 Cr in Mar'25, showing a steady growth trend. However, this is a decline from a peak of 19.76 Cr in Mar'19. The total operating income followed a similar pattern, rising to 12.90 Cr in Mar'25 from 12.18 Cr in Mar'24, yet down from 16.76 Cr in Mar'20. The total expenditure, excluding depreciation, has gradually increased to 8.82 Cr in Mar'25 from 8.04 Cr in Mar'23, indicating rising operational costs. Operating profit (PBDIT) improved to 4.48 Cr in Mar'25 from 3.94 Cr in Mar'24, although it remains lower than the 5.73 Cr recorded in Mar'19. Profit before tax also rose to 3.19 Cr in Mar'25, up from 2.38 Cr in Mar'24, while profit after tax increased to 2.23 Cr in Mar'25 from 1.76 Cr in Mar'24. The company's total assets decreased to 30.31 Cr in Mar'25 from 31.35 Cr in Mar'24, and total liabilities also fell to 30.31 Cr in Mar'25 from 31.35 Cr in Mar'24, reflecting a reduction in debt levels. Cash flow from operating activities was zero in Mar'25, down from 4.00 Cr in Mar'24, while cash flow from investing activities showed a positive inflow of 3.00 Cr in Mar'25. Overall, while Tejnaksh Health has shown some recovery in profitability, its sales and asset levels remain below historical highs.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
